Skip to main content
Log in

Stuporous states or coma induced by the rapid administration of high doses of sodium valproate

  • Original Articles
  • Published:
The Italian Journal of Neurological Sciences Aims and scope Submit manuscript

Abstract

7 cases of stuporous states or coma induced in epileptic subjects by the rapid administration of high doses of sodium valproate are described. Progressive impairment of consciousness began 2 to 7 days after the administration of sodium valproate and induced a slowing of background EEG activity until the delta activity became of high amplitude, generalized, continuous and areactive. The authors believe that the impairment of consciousness in their patients was related to the rapid administration of high doses and a direct intrinsic action of sodium valproate on the brain, as no increase in plasma levels of the drugs in association with valproate was observed.

Sommario

Sono descritti 7 casi di stupor o coma indotti, in soggetti epilettici, dalla somministrazione rapida di alte dosi di valproato di sodio. L'interessamento progressivo dello stato di coscienza inizia dopo 2–7 giorni dalla introduzione terapeutica del valproato di sodio;contemporaneamente sull'EEG l'attività di fondo rallenta fino alla comparsa di un 'attività delta di grande voltaggio, che appare continua, generalizzata ed areattiva. Gli autori ritengono che l'alterazione dello stato di coscienza sia da correlare ad una somministrazione rapida più che ad un 'azione diretta ed intrinseca del vaproato di sodio: in effetti questo non provoca alcun incremento dei livelli plasmatici dei farmaci prescritti in associazione.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Bellman M.H., Ross E.M.:Side effects of sodium valproate. Brit. Med. J., 1: 1662, 1977

    Article  Google Scholar 

  2. Cenraud B., Pautrizel B., Berets O., Loiseau P.:Troubles sévères de la vigilance: une complication exceptionnelle des traitements par le valproate de sodium. Rev. EEG Neurophysiol., 10: 376–380, 1980

    CAS  Google Scholar 

  3. Coulter D., Wu H., Allen R.:Valproic acid therapy in childhood epilepsy. JAMA, 244: 785, 1980

    PubMed  CAS  Google Scholar 

  4. Coulter D., Allen R.:Secondary hyperammonemia: a possible mechanism of valproate encephalopathy. Lancet, 1: 1310, 1980

    PubMed  CAS  Google Scholar 

  5. Coulter D., Allen R.:Hyperammonemia with valproic acid therapy. J. of Pediat., 99: 317–319, 1981

    CAS  Google Scholar 

  6. Chadwick D.W., Cumming W.B.K., Livingstone I., Cartlidge N.F.:Acute intoxication with sodium valproate. Ann. Neurol., 6: 552–553, 1979

    PubMed  CAS  Google Scholar 

  7. Garnier R., Fournier E.:Intoxication aiguë par le valproate de sodium. Nouv. Press. Méd., Paris, 3: 678, 1982

    Google Scholar 

  8. Lhermitte F., Marteau R., Serdaru M.:Dipropylacétate (valproate de sodium) et carbamazepine: une association antiépileptique suspecte. Nouv. Press. Méd., Paris, 7: 3780, 1978

    CAS  Google Scholar 

  9. Marescaux C., Micheletti G., Rumbach L., Warter J.:Episode confusionnel après addition d'un troisième antiépileptique à une association phenobarbital — valproate de sodium. Nouv. Press. Méd., 10: 1237, 1981

    CAS  Google Scholar 

  10. Marescaux C., Rumbach L., Warter J., Collard M., Rohmer F., Micheletti G., Kurtz D.:Etats stuporeux au cours des traitements par le valproate de sodium. Hypothèse pathogenique. Rev. Neurol., 137: 241–254, 1981

    PubMed  CAS  Google Scholar 

  11. Marescaux C., Bonardi J., Rumbach L., Warter J., Juif J., Micheletti G.:Etat stuporeux prolongé au cours d'une monotherapie au valproate de sodium immediatement réversible après injection intraveineuse de diazepam. Rev. Neurol., 137: 536–638, 1981

    Google Scholar 

  12. Meinardi H., Hanke N.F.J., Van Beveren J.:Sodium di-n-propylacetate. Estimation of effective serum levels. Pharm. Weekbl., 109; 45, 1974

    CAS  Google Scholar 

  13. Pinder R.M., Brodgen R.N., Speight T.M., Avery G.S.:Sodium valproate: a review of its pharmacological properties and therapeutic efficacy in epilepsy. Drugs, 13: 81–123, 1977

    PubMed  CAS  Google Scholar 

  14. Rai P.V.:Acute intoxication during a combined treatment of sodium valproate and phenobarbitone. In:Advances in epileptology, Meinardi H. and Rowen A.J. (Eds), Swets and Zeitlinger B.V., Amsterdam and Lisse, 366–369, 1979

    Google Scholar 

  15. Sackellares J.C., Lee S.I., Dreifuss F.E.:Stupor following administration of valproic acid to patients receiving other antiepileptic drugs. Epilepsia, 20: 697–703, 1979

    PubMed  CAS  Google Scholar 

  16. Sillis J., Treforjones R., Taylor W.:Valproate, hyperammonemia and hyperglycinemia. Lancet, 2: 260–261, 1980

    Google Scholar 

  17. Sugimoto T.,Yasuhara A.,Matsumura T.,Hara K.,Sakane Y.,Taniuchi K.:Hyperglycinemia and hyperammonemia following administration of valproic sodium. Abstracts, Epilepsy International Congress, p. 106, 1981

  18. Zazet B., Bechner R., Marini A.M., Wagle W., Passarelli C.:Sodium Valproate induced hyperammonemia without hepatic dysfunction. Neurology, 32: 206–208, 1982

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gastaut, H., Iemolo, F. Stuporous states or coma induced by the rapid administration of high doses of sodium valproate. Ital J Neuro Sci 3, 193–196 (1982). https://doi.org/10.1007/BF02043308

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02043308

Key-words

Navigation